Xi Cao
Translator — Chinese
China
Articles translated into Chinese by Xi Cao
- Drug to treat movement symptoms of HD approved by FDA
- Updates from PTC Therapeutics and uniQure on their huntingtin-lowering trials
- Huntington’s disease therapeutics conference 2023 - Day 2
- A new roadmap to track Huntington’s disease progression
- Oral drug may change the story for huntingtin lowering
- KINECT-HD trial shows valbenazine improves involuntary movements in Huntington's disease
- Updates from the EHDN Meeting 2021
- Unpacking recent gene therapy press
- Huntington’s disease clinical trial round up
- Huntington’s disease therapeutics conference 2021 - Day 1
- Disappointing Results from Wave’s PRECISION-HD1 and 2 Trials
- Sad News from Roche and Ionis - ASO Trial Halted Early
- Huntington Study Group (HSG) 2020 Annual Conference: HD in Focus - Day 1
- Huntington Study Group (HSG) 2020 Annual Conference: HD in Focus - Day 2
- Treatment for neurological disorder could be repurposed for Huntington’s disease patients
- Updates from the EHDN Plenary Meeting 2020
- When genes are unstable: targeting somatic instability in HD
- Caution urged for the use of gene-editing technology CRISPR
- HD and Histamines: Targeting Hybrid Receptors to Quiet Stressful Brain Talk
- HD Young Adult Study defines the sweet spot: symptom-free with measurable changes
- Fountain of youth: HTT protein repairs neurons by maintaining youthful state
- New molecule can reverse the Huntington's disease mutation in lab models
- What does COVID-19 mean for Huntington’s disease families and HD research?
- Huntington’s disease therapeutics conference 2020 - Day 3
- Huntington’s disease therapeutics conference 2020 - Day 2
- Huntington’s disease therapeutics conference 2020 - Day 1
- Unpacking Wave's PRECISION-HD2 huntingtin-lowering trial announcement
- Details emerge of first Huntington’s disease gene therapy clinical trial
- Huntington's disease therapeutics conference 2019 - Day 1
- Huntington's disease goes viral as UniQure inches ahead in gene therapy race
- Advances on many fronts in the battle against the protein that causes Huntington's disease
- Kids sometimes get Huntington’s disease too
- The structure of the protein that causes Huntington's disease, revealed
- Huntington's disease therapeutics conference 2018 - day 3
- Huntington's disease therapeutics conference 2018 - day 2
- Huntington's disease therapeutics conference 2018 - day 1
- Ask the expert: Q&A on the huntingtin-lowering trial program
- Success! ASO drug reduces levels of mutant protein in Huntington's disease patients
- Precision huntingtin-lowering drug trials target the mutant protein
- Update confirms Huntington's disease 'gene silencing' trial on track
- New study reveals a potential HD biomarker
- Huntington's Disease Therapeutics Conference 2017 - Day 3
- Huntington's Disease Therapeutics Conference 2017 - Day 2
- Huntington's Disease Therapeutics Conference 2017 - Day 1
- FDA approves a new drug for symptoms of Huntington's disease
- Sheep leading the flock: metabolism and biomarkers in HD
- The benefits of migration, highlighted in Huntington's disease
- Weeding out the truth: can cannabis improve Huntington’s?
- Treasure your exceptions - using outliers to understand Huntington's disease onset and progression
- A powerful message: does a toxic RNA message molecule cause harm in Huntington's disease?
- Pfizer Amaryllis trial ends in disappointment: no improvement in Huntington's disease symptoms
- Important advances in next generation genome editing tools for Huntington's Disease
- EuroBuzz 2016: The Euro-HD Network Meeting in The Hague
- Ultra-rare mutations highlight the importance of the HD gene in brain development
- Deutetrabenazine for Huntington's disease: a positive trial but the FDA says no? Not exactly...
- A support system gone wrong - glial cells contribute to HD symptoms
- Slightly long CAG repeats are more common than we thought
- Early exposure to the HD protein may cause life-long symptoms
- Electron beam snaps best images yet of Huntington's disease protein
- Planting trees together: The 2016 Huntington's Disease Society of America Convention
- Huntingtin takes a trip: harmful proteins pass between brain cells
- Important drug targets yielded by new genetic study of HD
- Thinking clearly about the earliest symptoms of HD and which brain regions control them
- Making babies: having a family, the HD way
- Could a new "jaw-dropping" breakthrough help treat Huntington's Disease?
- Huntington's Disease Therapeutics Conference 2016 - day 3
- Huntington's Disease Therapeutics Conference 2016 - day 2
- Huntington's Disease Therapeutics Conference 2016 - day 1
- A recycled drug gives us new insight in to HD
- Through the eyes of a friend: changes in mood and behavior in early HD
- A multiple sclerosis drug that works for Huntington's disease: the real deal or too good to be true?
- Liftoff: First humans treated with gene silencing drugs for HD!
- Measuring harmful huntingtin protein in the brain’s bath water
- Switching it up: variety in the HD gene affects symptom onset
- Lighting the way: A new biomarker for Huntington’s disease
- Building a Better Mouse(trap): A New Model of Huntington’s Disease
- Taking new targets to the bank: the DNA repair protein ‘ATM’ is overactive in Huntington's disease
- Drug Improves Huntington’s Symptoms in Mice – and Their Offspring
- mTORC1 tips the scales in Huntington’s disease mice
- Huntington's disease clinical trial announcement: huntingtin-lowering drug to enter Phase I trial in 2015
- Positive results announced for re-worked tetrabenazine drug in Huntington's disease
- Turning skin cells into brain cells: a Huntington's disease research breakthrough?
- 2CARE study of coenzyme Q for Huntington's disease ends in disappointment
- A starring role for astrocytes in Huntington's disease?